Table of Contents

• M Peakman,
• R D Leslie,
• L Alviggi,
• M Hawa,
• and D Vergani

Persistent activation of CD8+ T-cells characterizes prediabetic twins.

• G Fanghänel,
• L Sánchez-Reyes,
• C Trujillo,
• D Sotres,
• and J Espinosa-Campos

Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas.

• J L Chiasson,
• R G Josse,
• L A Leiter,
• M Mihic,
• D M Nathan,
• C Palmason,
• R M Cohen,
• and T M Wolever

The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.

• J Rosenstock,
• E Samols,
• D B Muchmore,
• and J Schneider

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

• L Juntti-Berggren,
• J Pigon,
• F Karpe,
• A Hamsten,
• M Gutniak,
• L Vignati,
• and S Efendic

The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients.

• A A Rivellese,
• A Maffettone,
• C Iovine,
• L Di Marino,
• G Annuzzi,
• M Mancini,
• and G Riccardi

Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.

• P Rossing,
• B V Hansen,
• F S Nielsen,
• B Myrup,
• G Hølmer,
• and H H Parving

Fish oil in diabetic nephropathy.

• R Seidl,
• R Birnbacher,
• E Hauser,
• G Bernert,
• M Freilinger,
• and E Schober

Brainstem auditory evoked potentials and visually evoked potentials in young patients with IDDM.

• H C Gerstein,
• J Bosch,
• J Pogue,
• D W Taylor,
• B Zinman,
• and S Yusuf

Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.

• T Rönnemaa,
• E M Rönnemaa,
• P Puukka,
• K Pyörälä,
• and M Laakso

Smoking is independently associated with high plasma insulin levels in nondiabetic men.

• G Zoppini,
• G Targher,
• T Monauni,
• G Faccini,
• E Pasqualini,
• C Martinelli,
• M L Zenari,
• and M Muggeo

Increase in circulating products of lipid peroxidation in smokers with IDDM.

• D E Kelley,
• R R Henry,
• and S V Edelman

Acute effects of intraperitoneal versus subcutaneous insulin delivery on glucose homeostasis in patients with NIDDM. Veterans Affairs Implantable Insulin Pump Study Group.

• S Savage,
• R O Estacio,
• B Jeffers,
• and R W Schrier

Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.

• D A Malerbi,
• E S Paiva,
• A L Duarte,
• and B L Wajchenberg

Metabolic effects of dietary sucrose and fructose in type II diabetic subjects.

• G Ha Van,
• H Siney,
• J P Danan,
• C Sachon,
• and A Grimaldi

Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery.

• E Faglia,
• F Favales,
• A Quarantiello,
• P Calia,
• G Brambilla,
• A Rampoldi,
• and A Morabito

Feasibility and effectiveness of peripheral percutaneous transluminal balloon angioplasty in diabetic subjects with foot ulcers.

• A M Carter,
• M W Mansfield,
• M H Stickland,
• and P J Grant

Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM.

• A Gault,
• K O'Dea,
• K G Rowley,
• T McLeay,
• and K Traianedes

Abnormal glucose tolerance and other coronary heart disease risk factors in an isolated aboriginal community in central Australia.

• V Mohan,
• G Premalatha,
• A Padma,
• S T Chari,
• and C S Pitchumoni

Fibrocalculous pancreatic diabetes. Long-term survival analysis.

• M P Garancini,
• C Gobbi,
• A Errera,
• A Sergi,
• and G Gallus

Age-specific incidence and duration of known diabetes. The Cremona Study.

• C Atlan-Gepner,
• P Bongrand,
• C Farnarier,
• L Xerri,
• R Choux,
• J F Gauthier,
• T Brue,
• P Vague,
• J J Grob,
• and B Vialettes

Insulin-induced lipoatrophy in type I diabetes. A possible tumor necrosis factor-alpha-mediated dedifferentiation of adipocytes.

• D Matthys,
• M Craen,
• D De Wolf,
• J Vande Walle,
• and H Verhaaren

Reduced decrease of peripheral vascular resistance during exercise in young type I diabetic patients.

• A J Jaap,
• H M Horn,
• M J Tidman,
• and J D Walker

Lipoatrophy with human insulin.

• F L Ferris, 3rd,
• E Y Chew,
• and B J Hoogwerf

Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group.

• H Warshaw,
• M Franz,
• M A Powers,
• and M Wheeler

Fat replacers: their use in foods and role in diabetes medical nutrition therapy.

Role of fat replacers in diabetes medical nutrition therapy. American Diabetes Association.

• Y Suzuki,
• K Tsukuda,
• Y Atsumi,
• Y Goto,
• K Hosokawa,
• T Asahina,
• I Nonaka,
• K Matsuoka,
• and Y Oka

Clinical picture of a case of diabetes with mitochondrial tRNA mutation at position 3271.

• R G Moses,
• D Calvert,
• and L H Storlien

Evaluation of the Accutrend GCT with respect to triglyceride monitoring.

• R W Lipp,
• W J Schnedl,
• and H F Hammer

Does postprandial walking influence delayed gastric emptying in patients with long-standing IDDM?

• H Sone,
• Y Okuda,
• Y Kawakami,
• M Hanatani,
• H Suzuki,
• T Kozawa,
• S Honmura,
• and K Yamashita

Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated.

• E R Bognetti,
• A Zoja,
• A Cogliardi,
• F Meschi,
• and G Chiumello

HbA1c assay on capillary blood sample collected at home: a reliable method.

• M Mazzella,
• M Cotellessa,
• W Bonacci,
• C Bruno,
• and G Serra

Neonatal diabetes and DQB1 typing.

• S Sugihara,
• M Kazukawa,
• S Konda,
• A Murata,
• K Wataki,
• Y Kobayashi,
• S Miyamoto,
• N Sasaki,
• and H Niimi

The prevalence of anti-bovine serum albumin antibodies in Japanese children with IDDM.

• Z T Bloomgarden

American Diabetes Association annual meeting 1996: the etiology of type II diabetes, obesity, and the treatment of type II diabetes.